ClinicalTrials.Veeva
Menu

Find clinical trials for Melanoma in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Renal Cell Carcinoma
Lung Cancer
Squamous Cell Carcinoma

Melanoma trials near New Haven, CT, USA:

Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma

This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma....

Enrolling
Melanoma
Metastatic Uveal Melanoma
Biological: Lifileucel (LN-144)

Phase 1

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Harrison, New York, United States and 1 other location

Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...

Active, not recruiting
Metastatic Melanoma
Biological: Lifileucel

Phase 2

Iovance Biotherapeutics

New Haven, Connecticut, United States and 56 other locations

and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before.The researchers think that a com...

Enrolling
Mucosal Melanoma
Radiation: Stereotactic Body Radiation Therapy (SBRT)
Drug: axitinib

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Harrison, New York, United States and 1 other location

is to test the effects of the study drug, ensartinib, on the patient and the cancer. Ensartinib is a new, investigational type of treatment for melanoma...

Active, not recruiting
Melanoma
Diagnostic Test: ALKATI by Customized Nanostring Assay
Drug: Ensartinib

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Harrison, New York, United States and 3 other locations

administered to participants with unresectable or metastatic melanoma.The study is divided into two phases: Phase 2 and Phase 3.The primary ...

Active, not recruiting
Advanced Melanoma
Melanoma
Drug: Nivolumab
Drug: CMP-001

Phase 2, Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Hartford, Connecticut, United States and 19 other locations

with the standard-of-care drug combination, nivolumab and relatlimab, is a safe and effective treatment for people with untreated, unresectable melanoma...

Enrolling
Melanoma
Drug: IO102/IO103
Drug: Nivolumab-Relatlimab

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Hartford, Connecticut, United States and 8 other locations

study to evaluate the efficacy, safety, and tolerability of APX005M in combination with nivolumab and ipilimumab in patients with advanced melanoma...

Enrolling
Advanced Melanoma
Renal Cell Carcinoma
Drug: APX005M
Drug: Nivolumab

Phase 1

Yale University
Yale University

New Haven, Connecticut, United States and 1 other location

This is a phase 2, Simon's 2-stage designed study with 2 cohorts of anti-PD-1/PD-L1 experienced patients with untreated brain metastases: 1) melanoma...

Enrolling
Melanoma
Metastatic Melanoma
Drug: Pembrolizumab
Drug: Lenvatinib

Phase 2

Yale University
Yale University

New Haven, Connecticut, United States

and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma...

Enrolling
Melanoma
Drug: mRNA-4157
Biological: Pembrolizumab

Phase 2

Moderna
Moderna

New Haven, Connecticut, United States and 20 other locations

with relapsed or refractory (R/R) metastatic or locally advanced melanoma, non-small cell lung cancer (NSCLC), and colorectal cancer (CRC)....

Enrolling
Melanoma
Non-small Cell Lung Cancer
Biological: LYL845

Phase 1

Lyell Immunopharma

New Haven, Connecticut, United States and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems